PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers

Justine Paris, Claire Wilhelm, Celeste Lebbé, Mohammed Elmallah, Frédéric Pamoukdjian, Audrey Héraud, Guillaume Gapihan, Aurore Van De Walle, Van Nhan Tran, Diaddin Hamdan, Clara Allayous, Maxime Battistella, Emmanuel Van Glabeke, Kah Wai Lim, Christophe Leboeuf, Sébastien Roger, Géraldine Falgarone, Anh Tuan Phan, Guilhem Bousquet

Open source

DOI: 10.1002/ctm2.1632
Published: 2024-03
Container: Clinical and Translational Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.1632,
  title = {PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers},
  author = {Justine Paris and Claire Wilhelm and Celeste Lebbé and Mohammed Elmallah and Frédéric Pamoukdjian and Audrey Héraud and Guillaume Gapihan and Aurore Van De Walle and Van Nhan Tran and Diaddin Hamdan and Clara Allayous and Maxime Battistella and Emmanuel Van Glabeke and Kah Wai Lim and Christophe Leboeuf and Sébastien Roger and Géraldine Falgarone and Anh Tuan Phan and Guilhem Bousquet},
  year = {2024},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.1632},
  url = {https://doi.org/10.1002/ctm2.1632}
}

RIS

TY  - JOUR
TI  - PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers
AU  - Justine Paris
AU  - Claire Wilhelm
AU  - Celeste Lebbé
AU  - Mohammed Elmallah
AU  - Frédéric Pamoukdjian
AU  - Audrey Héraud
AU  - Guillaume Gapihan
AU  - Aurore Van De Walle
AU  - Van Nhan Tran
AU  - Diaddin Hamdan
AU  - Clara Allayous
AU  - Maxime Battistella
AU  - Emmanuel Van Glabeke
AU  - Kah Wai Lim
AU  - Christophe Leboeuf
AU  - Sébastien Roger
AU  - Géraldine Falgarone
AU  - Anh Tuan Phan
AU  - Guilhem Bousquet
PY  - 2024
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.1632
UR  - https://doi.org/10.1002/ctm2.1632
ER  -

APA

Paris, J., Wilhelm, C., Lebbé, C., Elmallah, M., Pamoukdjian, F., Héraud, A., Gapihan, G., Walle, A. V. D., Tran, V. N., Hamdan, D., Allayous, C., Battistella, M., Glabeke, E. V., Lim, K. W., Leboeuf, C., Roger, S., Falgarone, G., Phan, A. T., & Bousquet, G. (2024). PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1632

Source records

crossref · retrieved 2026-11-03T21:37:14.881Z